Novel restraint
18-0353-01
Phase 1 other completed
Quick answer
Novel restraint for Acute Respiratory Failure is a Phase 1 program (other) at Lxo Ireland Designated Activity Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lxo Ireland Designated Activity Company
- Indication
- Acute Respiratory Failure
- Phase
- Phase 1
- Modality
- other
- Status
- completed